Applying an Immunogenicity Risk-Based Approach to Gene Therapy Products

Time: 3:00 pm
day: Day 2 Track 2 PM

Details:

  • Current regulatory expectations
  • Immune responses to gene therapies
  • Evaluation and mitigation strategies

Speakers: